Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2011, Article ID 637692, 24 pages
http://dx.doi.org/10.1155/2011/637692
Review Article

Current Status of Immunomodulatory and Cellular Therapies in Preclinical and Clinical Islet Transplantation

1Department of Surgery, University of Virginia, Charlottesville, VA 22908, USA
2Division of Transplantation, Department of Surgery, University of Virginia, Charlottesville, VA 22908, USA
3The Center for Cellular Transplantation and Therapeutics, University of Virginia, Charlottesville, VA 22908, USA

Received 1 May 2011; Accepted 11 July 2011

Academic Editor: Antonello Pileggi

Copyright © 2011 Preeti Chhabra and Kenneth L. Brayman. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [18 citations]

The following is the list of published articles that have cited the current article.

  • Preeti Chhabra, Kailo Schlegel, Mark D. Okusa, Peter I. Lobo, and Kenneth L. Brayman, “Naturally Occurring Immunoglobulin M (nIgM) Autoantibodies Prevent Autoimmune Diabetes and Mitigate Inflammation After Transplantation,” Annals of Surgery, vol. 256, no. 4, pp. 634–641, 2012. View at PublisherView at Google Scholar
  • Emily Sims, and Carmella Evans-Molina, “Stem cells as a tool to improve outcomes of islet transplantation.,” Journal of transplantation, vol. 2012, pp. 736491, 2012. View at PublisherView at Google Scholar
  • Preeti Chhabra, and Kenneth L. Brayman, “Stem Cell Therapy to Cure Type 1 Diabetes: From Hype to Hope,” Stem Cells Translational Medicine, vol. 2, no. 5, pp. 328–336, 2013. View at PublisherView at Google Scholar
  • Preeti Chhabra, and Kenneth L. Brayman, “Overcoming Barriers in Clinical Islet Transplantation: Current Limitations and Future Prospects,” Current Problems in Surgery, 2013. View at PublisherView at Google Scholar
  • Li-Bin Guo, Sheng-Nan Guo, Ying Liu, Dong-Lin Cao, Hong-Feng Zhuang, and Jin-Kai Xu, “Amniotic stem cell transplantation therapy for type 1 diabetes: A case report,” Journal Of International Medical Research, vol. 41, no. 4, pp. 1370–1377, 2013. View at PublisherView at Google Scholar
  • Brian Buder, Michael Alexander, Rahul Krishnan, David W Chapman, and Jonathan RT Lakey, “Encapsulated Islet Transplantation: Strategies and Clinical Trials,” Immune Network, vol. 13, no. 6, pp. 235, 2013. View at PublisherView at Google Scholar
  • Jonathan R. T. Lakey, Morgan Lamb, Michael Alexander, David Chapman, David Imagawa, and Rahul Krishnan, “Islet Xenotransplantation: An Update on Recent Advances and Future Prospects,” Islets of Langerhans, 2. ed., pp. 1–20, 2014. View at PublisherView at Google Scholar
  • Rahul Krishnan, Rajan P. Arora, Michael Alexander, Sean M. White, Morgan W. Lamb, Clarence E. Foster, Bernard Choi, and Jonathan R. T. Lakey, “Noninvasive evaluation of the vascular response to transplantation of alginate encapsulated islets using the dorsal skin-fold model,” Biomaterials, vol. 35, no. 3, pp. 891–898, 2014. View at PublisherView at Google Scholar
  • Mazhar A. Kanak, Morihito Takita, Faisal Kunnathodi, Michael C. Lawrence, Marlon F. Levy, and Bashoo Naziruddin, “Inflammatory Response in Islet Transplantation,” International Journal of Endocrinology, vol. 2014, pp. 1–13, 2014. View at PublisherView at Google Scholar
  • Haitao Zhu, Liang Yu, Yayi He, and Bo Wang, “Nonhuman Primate Models of Type 1 Diabetes Mellitus for Islet Transplantation,” Journal of Diabetes Research, vol. 2014, pp. 1–9, 2014. View at PublisherView at Google Scholar
  • Lourdes Robles, Rick Storrs, Morgan Lamb, Michael Alexander, and Jonathan R. T. Lakey, “Current Status of Islet Encapsulation,” Cell Transplantation, vol. 23, no. 11, pp. 1321–1348, 2014. View at PublisherView at Google Scholar
  • F. J. Choong, C. Freeman, C. R. Parish, and C. J. Simeonovic, “Islet Heparan Sulfate but Not Heparan Sulfate Proteoglycan Core Protein Is Lost During Islet Isolation and Undergoes Recovery Post-Islet Transplantation,” American Journal of Transplantation, 2015. View at PublisherView at Google Scholar
  • Matthew W Klinker, and Cheng-Hong Wei, “Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models.,” World journal of stem cells, vol. 7, no. 3, pp. 556–67, 2015. View at PublisherView at Google Scholar
  • Vincent L. Leung, and Jayachandran N. Kizhakkedathu, “The mechanism and modulation of complement activation on polymer grafted cells,” Acta Biomaterialia, 2015. View at PublisherView at Google Scholar
  • Rahul Krishnan, Morgan Lamb, Lakey, Michael Alexander, David Chapman, and David Imagawapp. 1275–1296, 2015. View at PublisherView at Google Scholar
  • Wei Nie, Xiaoqian Ma, Cejun Yang, Zeyi Chen, Pengfei Rong, Minghua Wu, Jianhui Jiang, Mengqun Tan, Shounan Yi, and Wei Wang, “Human mesenchymal-stem-cells-derived exosomes are important in enhancing porcine islet resistance to hypoxia,” Xenotransplantation, pp. e12405, 2018. View at PublisherView at Google Scholar
  • Ali Zafar, Jou Lee, Shameema Yesmin, Michelle B. Paget, Clifford J. Bailey, Hilary E. Murray, and Richard Downing, “Rotational culture and integration with amniotic stem cells reduce porcine islet immunoreactivity in vitro and slow xeno‐rejection in a murine model of islet transplantation,” Xenotransplantation, pp. e12508, 2019. View at PublisherView at Google Scholar
  • Prakash Shrestha, Shobha Regmi, and Jee-Heon Jeong, “Injectable hydrogels for islet transplantation: a concise review,” Journal of Pharmaceutical Investigation, 2019. View at PublisherView at Google Scholar